LINC01896
gene geneOn this page
Summary
LINC01896 (long intergenic non-protein coding RNA 1896, HGNC:52715) is a long non-coding RNA gene on chromosome 18q23.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:52715 |
| Approved symbol | LINC01896 |
| Name | long intergenic non-protein coding RNA 1896 |
| Location | 18q23 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Ensembl gene | ENSG00000263146 |
| Ensembl biotype | lncRNA |
| Entrez | 645321 |
| RNAcentral | URS00026A1C44 — lncRNA, 1801 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 9 lncRNA
ENST00000572007, ENST00000573860, ENST00000575722, ENST00000583511, ENST00000824724, ENST00000824725, ENST00000824726, ENST00000824727, ENST00000824728
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000572007 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00004234258 | 78976814 | 78977429 |
| ENSE00004234259 | 78977555 | 78978011 |
Expression profiles
Bgee: expression breadth ubiquitous, 106 present calls, max score 96.53.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.4883 / max 21.9541, expressed in 148 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 172634 | 0.4079 | 131 |
| 172633 | 0.0804 | 37 |
Top tissues by expression
106 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| C1 segment of cervical spinal cord | UBERON:0006469 | 96.53 | gold quality |
| putamen | UBERON:0001874 | 95.58 | gold quality |
| caudate nucleus | UBERON:0001873 | 95.31 | gold quality |
| ventricular zone | UBERON:0003053 | 95.22 | gold quality |
| amygdala | UBERON:0001876 | 95.16 | gold quality |
| temporal lobe | UBERON:0001871 | 95.07 | gold quality |
| nucleus accumbens | UBERON:0001882 | 94.95 | gold quality |
| substantia nigra | UBERON:0002038 | 94.51 | gold quality |
| Ammon’s horn | UBERON:0001954 | 92.84 | gold quality |
| hypothalamus | UBERON:0001898 | 92.77 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 92.73 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 91.38 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 91.30 | gold quality |
| right frontal lobe | UBERON:0002810 | 90.88 | gold quality |
| cerebral cortex | UBERON:0000956 | 90.56 | gold quality |
| ganglionic eminence | UBERON:0004023 | 89.07 | gold quality |
| frontal cortex | UBERON:0001870 | 88.82 | gold quality |
| primary visual cortex | UBERON:0002436 | 88.55 | gold quality |
| prefrontal cortex | UBERON:0000451 | 87.55 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 85.94 | gold quality |
| brain | UBERON:0000955 | 85.68 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 84.59 | gold quality |
| vagina | UBERON:0000996 | 84.59 | gold quality |
| corpus callosum | UBERON:0002336 | 82.43 | gold quality |
| prostate gland | UBERON:0002367 | 81.71 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 80.02 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 79.37 | gold quality |
| left testis | UBERON:0004533 | 76.70 | gold quality |
| kidney | UBERON:0002113 | 76.24 | gold quality |
| testis | UBERON:0000473 | 75.79 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.34 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.